Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis
Conditions:   HIV Infection Primary;   Hepatitis, Viral, Human;   Sexually Transmitted Infections, Excluding HIV and Hepatitis Intervention:   Drug: Tenofovir Disoproxil Fumarate 300 MG Oral Tablet Sponsors:   Hospitales Universitarios Virgen del Rocío;   Instituto de Biomedicina de Sevilla Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2022 Category: Research Source Type: clinical trials